Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”
Author(s) -
Mojun Zhu,
Tanios BekaiiSaab
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac068
Subject(s) - radionuclide therapy , peptide receptor , medicine , neuroendocrine tumors , cancer research , oncology , receptor , homologous recombination , genetics , dna , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom